Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Xencor to Present at Upcoming Investor Conferences


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced that company management will participate at multiple upcoming investor conferences:

Live webcasts of the Cowen, Leerink and Barclays presentations will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.

About Xencor

Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.


These press releases may also interest you

at 09:10
Mosyle, the only Apple Unified Platform, today announced the launch of Mosyle Fuse MSP, the first solution that integrates five critical management and security applications into a single, Apple-only product specifically designed for Managed Service...

at 09:10
FundingShield is pleased to announce that John Hedlund has joined its advisory board. John Hedlund, founder of Adanac Advisory Group (AAG), a boutique advisory and consulting firm, recently retired from AmeriHome Mortgage, a Western Alliance Bank...

at 09:10
Siri's first Head of Product and Design, Mads Rydahl, has funneled his extensive knowledge of AI and Large Language Models (LLMs) into a new company; Proemial. The startup, co-founded by serial entrepreneur Geet Khosla and tech veteran Brian...

at 09:10
Orca Security, the leader in agentless cloud security, today announced significant new capabilities and services that enable rapid investigation and response to cloud-native infrastructure attacks. With the general availability of cloud digital...

at 09:06
Daqo New Energy Corp. ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31,...

at 09:05
GE HealthCare today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor that can provide clinicians with an accurate view of patient vital signs to support...



News published on and distributed by: